Spots Global Cancer Trial Database for Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
Official Title: A Study to Evaluate Safety, Immunogenicity and Efficacy of GSK Biologicals HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a Three-dose Schedule (0, 1, 6 Month) in Healthy Adult Female Subjects Aged 26 Years and Above
Study ID: NCT00294047
Study Description
Brief Summary: This is a multicentre study in which women were planned to receive either the Human Papillomavirus Vaccine (HPV) vaccine or control. Under Protocol Amendment 3, study participation will last approximately 48 months and involves a total of eleven scheduled visits. Under Protocol Amendment 4, study participation will last up to 84 months and involves a maximum of seventeen scheduled visits.
Detailed Description: The Protocol Posting has been updated due to protocol amendment 5 and in order to comply with the FDA Amendment Act, Sep 2007.
Eligibility
Minimum Age: 26 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
GSK Investigational Site, Fountain Valley, California, United States
GSK Investigational Site, Aurora, Colorado, United States
GSK Investigational Site, Golden, Colorado, United States
GSK Investigational Site, Coral Gables, Florida, United States
GSK Investigational Site, Miami, Florida, United States
GSK Investigational Site, Augusta, Georgia, United States
GSK Investigational Site, Iowa City, Iowa, United States
GSK Investigational Site, Wichita, Kansas, United States
GSK Investigational Site, Bardstown, Kentucky, United States
GSK Investigational Site, Louisville, Kentucky, United States
GSK Investigational Site, Chaska, Minnesota, United States
GSK Investigational Site, Omaha, Nebraska, United States
GSK Investigational Site, Lebanon, New Hampshire, United States
GSK Investigational Site, Albuquerque, New Mexico, United States
GSK Investigational Site, Syracuse, New York, United States
GSK Investigational Site, Chapel Hill, North Carolina, United States
GSK Investigational Site, New Bern, North Carolina, United States
GSK Investigational Site, Akron, Ohio, United States
GSK Investigational Site, Cleveland, Ohio, United States
GSK Investigational Site, Tulsa, Oklahoma, United States
GSK Investigational Site, Portland, Oregon, United States
GSK Investigational Site, Carnegie, Pennsylvania, United States
GSK Investigational Site, Erie, Pennsylvania, United States
GSK Investigational Site, Erie, Pennsylvania, United States
GSK Investigational Site, Philadelphia, Pennsylvania, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Pittsburgh, Pennsylvania, United States
GSK Investigational Site, Wexford, Pennsylvania, United States
GSK Investigational Site, Austin, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Salt Lake City, Utah, United States
GSK Investigational Site, Salt Lake City, Utah, United States
GSK Investigational Site, South Jordan, Utah, United States
GSK Investigational Site, Wenatchee, Washington, United States
GSK Investigational Site, La Crosse, Wisconsin, United States
GSK Investigational Site, Parkville, Victoria, Australia
GSK Investigational Site, Perth, Western Australia, Australia
GSK Investigational Site, Edmonton, Alberta, Canada
GSK Investigational Site, Vancouver, British Columbia, Canada
GSK Investigational Site, Halifax, Nova Scotia, Canada
GSK Investigational Site, Truro, Nova Scotia, Canada
GSK Investigational Site, Waterloo, Ontario, Canada
GSK Investigational Site, Sherbrooke, Quebec, Canada
GSK Investigational Site, Quebec, , Canada
GSK Investigational Site, Cuenavaca, Morelos, Mexico
GSK Investigational Site, Jojutla / Morelos, , Mexico
GSK Investigational Site, Amsterdam, , Netherlands
GSK Investigational Site, Delft, , Netherlands
GSK Investigational Site, Rotterdam, , Netherlands
GSK Investigational Site, Lima, , Peru
GSK Investigational Site, Laguna, , Philippines
GSK Investigational Site, San Pablo City, , Philippines
GSK Investigational Site, Taft Avenue, Manila, , Philippines
GSK Investigational Site, Almada, , Portugal
GSK Investigational Site, Coimbra, , Portugal
GSK Investigational Site, Lisboa, , Portugal
GSK Investigational Site, Porto, , Portugal
GSK Investigational Site, Setúbal, , Portugal
GSK Investigational Site, Ekaterinburg, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Sankt-Petersburg, , Russian Federation
GSK Investigational Site, Sankt-Petersburg, , Russian Federation
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Northwood, Middlesex, United Kingdom
GSK Investigational Site, Aberdeen, , United Kingdom
GSK Investigational Site, Cardiff, , United Kingdom
GSK Investigational Site, Gateshead, , United Kingdom
GSK Investigational Site, London, , United Kingdom
GSK Investigational Site, Manchester, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
